v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash Flows from Operating Activities:    
Net Income $ 17,115 $ 16,264
Provision for Credit Losses 5,613 1,392
Depreciation and Amortization 2,619 2,644
Net Gain on Equity Securities (277) (71)
Loans Originated and Held-for-Sale (14,514) (833)
Proceeds from the Sale of Loans Held-for-Sale 11,013 9
Net Gain on the Sale of Loans (314) (9)
Net Gain on the Sale of Premises and Equipment, Other Real Estate Owned and Repossessed Assets (59) (334)
Contributions to Retirement Benefit Plans (339) (336)
Deferred Income Tax Benefit (123) (252)
Shares Issued Under the Directors’ Stock Plan 251 256
Stock-Based Compensation Expense 422 164
Tax Benefit from Exercise of Stock Options 111 39
Net Decrease (Increase) in Other Assets 1,027 (2,970)
Net (Decrease) Increase in Other Liabilities (2,197) 3,465
Net Cash Provided By Operating Activities 20,348 19,428
Cash Flows from Investing Activities:    
Proceeds from maturities, calls, and principal repayments of securities AFS 68,437 46,298
Purchases of securities AFS (39,623) 0
Proceeds from maturities, calls, and principal repayments of securities HTM 33,932 33,076
Purchases of securities HTM (6,570) (1,197)
Net increase in loans (42,488) (109,992)
Proceeds from Sales of Premises and Equipment, OREO and Repos 1,439 2,230
Purchases of premises and equipment (3,276) (2,719)
(Purchase) Redemption of FHLB stock (204) 775
Net Cash Provided (Used) By Investing Activities 11,647 (31,529)
Cash Flows from Financing Activities:    
Net increase (decrease) in deposits 101,400 (3,927)
Finance Lease Payments (36) (28)
Other borrowings - Advances 0 100,000
Other borrowings - Paydowns 0 (20,000)
Net Cash Collateral (paid to) received from derivative counterparties (1,710) 8,970
Purchase of Treasury Stock (8,654) (6,471)
Stock options exercised, net 102 166
Shares issued under ESPP 165 129
Cash Dividends paid (9,360) (9,076)
Net Cash Provided By Financing Activities 81,907 69,763
Net Increase in Cash and Cash Equivalents 113,902 57,662
Cash and Cash Equivalents at Beginning of Period 154,546 142,536
Cash and Cash Equivalents at End of Period 268,448 200,198
Supplemental Disclosures to Statements of Cash Flow Information:    
Interest on Deposits and Borrowings 37,730 37,625
Income Taxes 4,207 3,553
Transfer of Loans to Other Real Estate Owned and Repossessed Assets 1,431 1,079
Total fair value of Commercial Loan Participation transferred to Other Assets $ 10,648 $ 0